NIH Scientists Rebel Against Political Interference
Summary:
Over 340 NIH researchers have signed the Bethesda Declaration, challenging their director to reverse grant cuts targeting diversity and climate research whilst Trump proposes slashing the agency’s budget by 40%.
Perspective Therapeutics Powers Up Radiotherapy Revolution
Summary:
Seattle’s Perspective Therapeutics showcased impressive 50% response rates for their lead-based cancer treatment at ASCO25, outperforming standard care’s 13% whilst scaling manufacturing across three US cities.
Daiichi Sankyo’s New CEO Charts Course Beyond ADC Success
Summary:
CEO Hiroyuki Okuzawa inherits a cancer drug empire built on antibody-drug conjugates worth billions, but must now identify the next breakthrough whilst navigating potential US tariffs on pharmaceutical imports.
Omada Health Breaks Digital Health IPO Drought
Summary:
Digital chronic disease management pioneer Omada Health debuted at $23 per share, marking a 21% surge and signalling renewed investor confidence in the previously struggling digital health sector.
Medical AI Regulation Struggles to Match Innovation Pace
Summary:
Researchers warn that over 1,000 FDA-approved medical AI tools lack proper oversight as hospitals adopt them rapidly, calling for enhanced safeguards beyond current regulatory frameworks to ensure patient safety.
